Drug Interaction Report

Simvastatin and Pibrentasvir: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 4, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Simvastatin

Flolipid Flolipid® Zocor Zocor®
+

Pibrentasvir

No brand names on record
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 4, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 168 documented Simvastatin interactions, 99 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Effects may be stronger
The Bottom Line
Taking simvastatin with glecaprevir/pibrentasvir sharply raises simvastatin levels and the risk of serious muscle problems, so this pairing is not recommended. Talk with your doctor or pharmacist about a safer cholesterol option.

You've been prescribed simvastatin (a cholesterol medicine) along with glecaprevir/pibrentasvir, a hepatitis C treatment. When these are taken together, the hepatitis C medicine causes much more simvastatin to build up in your blood. In a study, the active form of simvastatin rose several times higher than normal.

That extra buildup raises the risk of muscle problems, like aching, weakness, or in rare cases serious muscle breakdown. The good news is your care team knows about this combination and can manage it, often by choosing a different cholesterol medicine. Please don't stop anything on your own, just talk with your doctor or pharmacist.

Effect: Coadministration markedly increases simvastatin exposure and raises myopathy/rhabdomyolysis risk. In a PK study (N=12), simvastatin Cmax rose 99% and AUC 132%; simvastatin acid (active metabolite) Cmax rose 970% and AUC 348%.

Mechanism: Unknown per file, but consistent with glecaprevir/pibrentasvir inhibition of hepatic uptake/metabolism transporters affecting simvastatin disposition.

Direction: Increased statin effect and toxicity risk. Evidence: Established. Severity: Major.

  • Concurrent use is not recommended.
  • Consider an alternative lipid-lowering agent per label guidance.
  • Monitor for myalgia, weakness, and CK elevation if exposure occurs.
Onset
unspecified
Evidence
established
Severity
Major

What happens

Increased simvastatin exposure and increased risk of myopathy

Interaction Deep Dive

Taking glecaprevir/pibrentasvir together with simvastatin is not advised. Combining these agents can raise simvastatin plasma concentrations and heighten the likelihood of myopathy, including rhabdomyolysis. Findings from a pharmacokinetic study (N=12) showed that when simvastatin 5 mg once daily was given alongside glecaprevir 300 mg/pibrentasvir 120 mg once daily, the Cmax of simvastatin rose by 99% and its AUC by 132%, whereas simvastatin acid demonstrated a 970% increase in Cmax and a 348% increase in AUC1.

Why it happens (mechanism)

Unknown

How to manage this interaction

This combination is not recommended because the hepatitis C therapy pushes simvastatin levels much higher, raising the chance of muscle injury.

  • Keep taking both exactly as prescribed until you speak with your care team, do not stop on your own.
  • Your team will likely choose a different cholesterol medicine while you are on the hepatitis C treatment.
  • Report any muscle pain, tenderness, weakness, or dark urine right away.
  • Ask your pharmacist or prescriber which statin or alternative is best for you.

Management is individual — confirm any change with your pharmacist or prescriber.

Literature reports

1 report — tap to read

a) In a pharmacokinetic study (N=12), coadministration of simvastatin 5 mg once daily with glecaprevir 300 mg/pibrentasvir 120 mg once daily produced a 99% rise in simvastatin Cmax and a 132% rise in AUC, whereas simvastatin acid Cmax rose by 970% and AUC rose by 348% 1.

Common questions

Can I take Simvastatin and Pibrentasvir together?

Taking simvastatin with glecaprevir/pibrentasvir sharply raises simvastatin levels and the risk of serious muscle problems, so this pairing is not recommended. Talk with your doctor or pharmacist about a safer cholesterol option. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Simvastatin and Pibrentasvir interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Simvastatin and Pibrentasvir interaction managed?

This combination is not recommended because the hepatitis C therapy pushes simvastatin levels much higher, raising the chance of muscle injury. Keep taking both exactly as prescribed until you speak with your care team, do not stop on your own. Your team will likely choose a different cholesterol medicine while you are on the hepatitis C treatment. Report any muscle pain, tenderness, weakness, or… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "established". Well documented — supported by controlled studies or strong clinical data.

From our Q&A

Real reader questions about these medications, each personally answered by our pharmacist:

Questions for your pharmacist

  • Does my dose of Simvastatin or Pibrentasvir need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Product Information: MAVYRET(R) oral tablets, oral pellets, glecaprevir pibrentasvir oral tablets, oral pellets. AbbVie Inc (per FDA), North Chicago, IL, 2023. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.